Syngene

BSE: 539268 | NSE: SYNGENE
Syngene (CIN: L85110KA1993PLC014937) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Aug 2015. It currents trades on NSE with symbol SYNGENE and on BSE with scrip code 539268.
The registered office of the company is Biocon Park SEZ, Jigani Link Road, Bommasandra IV Phase,Bengaluru,Karnataka,560099.

The management team of Syngene is led by Mr. JOHN SHAW who is the Non-Executive - Non Independent Director. Other members of the management team consist of Mr. JONATHAN HUNT (Designation:Executive Director-CEO), Ms. CATHERINE ROSENBERG (Designation:Non-Executive - Non Independent Director), Mr. PAUL BLACKBURN (Designation:Non-Executive - Independent Director), Mr. VIJAY KUCHROO (Designation:Non-Executive - Independent Director), Ms. VINITA BALI (Designation:Non-Executive - Independent Director), Mr. BALA S MANIAN (Designation:Non-Executive - Independent Director), Mrs. SHARMILA ABHAY KARVE (Designation:Non-Executive - Independent Director), Mr. CARL DECCICO (Designation:Non-Executive - Independent Director), Mr. Sibaji Biswas (Designation:Chief Financial Officer), Ms. Priyadarshini Mahapatra (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Syngene is as below -
Symbol is not Traded Today for BSE

NSE 442.80 12.75 (2.96%)

NSE

442.80 12.75 (2.96%)
Volume: 25,54,851.00
M. Cap: 17,610.00
P/E: 49.97
Prev. Close: 430.05
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 28,27,49,697 70.69
Foreign Institutions 5,36,28,771 13.41
NBFC and Mutual Funds 3,28,00,583 8.20
Others 28,73,591 0.72
General Public 2,00,76,944 5.02
Financial Institutions 43,99,989 1.10
ForeignPromoter 7,000 0.00
GDR 34,63,425 0.87
Total 40,00,00,000 100.01

NSE Trade Data

Trade Snapshot
VWAP 440.15
Face Value 10.00
Traded Volume (shares) 25,54,851.00
Traded Value (lacs) 11,245.18
Free Float Market Cap (Crs) 4,929.12
52 week high 475.45
52 week low 212.55
Lower Price Band 344.05
Upper Price Band 516.05
Security-wise Delivery Position
Quantity Traded 25,54,851.00
Deliverable Quantity (gross across client level) 19,43,308.00
% of Deliverable Quantity to Traded Quantity 76.06 %
Value at Risk (VaR in %)
Security VaR 13.44
Index VaR -
VAR Margin 13.44
Extreme Loss Rate 3.50
Adhoc Margin 23.06
Applicable Margin Rate 40.00

Financial Data

Consolidated
Figures in crore 2019 2018
Net Sales 1,825.60 1,423.10
Operating Profit 611.90 526.60
Other Income 75.10 61.80
Interest 32.30 22.70
Depreciation 164.20 131.40
Profit Before Tax 415.40 372.50
Tax 83.80 67.10
Profit After Tax 331.60 305.40
Share Capital 200.00 200.00
Reserves 1,768.40 1,520.40
Net Worth 1,968.40 1,720.40
Loans 1,058.10 886.90
Gross Block 2,171.00 1,660.70
Investments 716.00 157.70
Cash 436.90 967.40
Debtors 338.70 266.80
Net Working Capital 660.00 1,263.80
Operating Profit Margin (%) 33.52 37.00
Net Profit Margin (%) 18.16 21.46
Earning Per Share (Rs) 16.58 15.27
Dividend (%) 5.00 10.00
Dividend Payout 24.10 24.10
Standalone
Figures in crore 2020 2019 2018
Net Sales 2,011.90 1,825.60 1,423.10
Operating Profit 769.60 610.70 526.20
Other Income 152.90 75.10 61.80
Interest 34.60 32.30 22.70
Depreciation 219.30 164.20 131.40
Profit Before Tax 515.70 414.20 372.10
Tax 104.20 83.50 67.00
Profit After Tax 411.50 330.70 305.10
Share Capital 400.00 200.00 200.00
Reserves 1,774.10 1,767.20 1,520.10
Net Worth 2,174.10 1,967.20 1,720.10
Loans 1,139.60 1,058.10 886.90
Gross Block 3,017.20 2,171.00 1,660.70
Investments 776.70 716.30 158.00
Cash 280.30 435.40 966.50
Debtors 398.20 338.70 266.80
Net Working Capital 283.20 658.50 1,263.20
Operating Profit Margin (%) 38.25 33.45 36.98
Net Profit Margin (%) 20.45 18.11 21.44
Earning Per Share (Rs) 10.29 16.54 15.26
Dividend (%) 0.00 5.00 10.00
Dividend Payout 24.10 24.10 24.10
Dividend Declared (₹)
The company has declared dividend 4 times between 17 Mar 2016 and 16 Jul 2019, totaling Rs. 3.00 so far. The most recent dividend was declared on 16 Jul 2019 for Rs. 0.5.
Bonus History
Date Ratio
11 Jun 2019 issue 1:1

Financial Data Graph

The peers of Syngene are AUROPHARMA, NECLIFE and AJANTPHARM.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.